Share

Updates matching "National"

September 25, 2017
National

Changes to the nation’s healthcare system as proposed in the pending Graham-Cassidy health legislation could leave millions of cancer patients and survivors without access to adequate, affordable health insurance coverage, according to Dick Woodruff, senior vice president of federal advocacy for ACS CAN.

September 14, 2017
National

This week the Senate HELP Committee is hearing from bipartisan health care experts in its ongoing effort to strengthen the individual insurance market and ensure that meaningful, affordable health care coverage is available for millions of Americans, including cancer patients, survivors and their families.

September 13, 2017
National

Place your cursor over the image and use the arrows to scroll through this fabulous album of pictures.

September 10, 2017
National

Every year, ACS CAN launches its annual Leadership Summit and Lobby Day by honoring the volunteers and staff for their incredible achievements. This group of high-performing advocates played a critical role in our legislative success during the past year. We are so grateful to all of our volunteers and staff

September 7, 2017
National

Across the country during August, ACS CAN volunteers were making sure members of Congress heard loud and clear that fighting cancer must be a national priority. From leading public rallies to delivering tens of thousands of petitions directly to lawmaker offices, our volunteers were highly visible, always enthusiastic and, of

September 6, 2017
National

Childhood cancer is the leading cause of disease-related death among children ages one to 19. Breakthroughs in childhood cancer research have led to more and more children surviving their cancer diagnosis, but progress in treating certain types of cancer remains limited. And, children who survive cancer, often must deal with

August 15, 2017
National

The Congressional Budget Office (CBO) today released its assessment of what would happen to health insurance premiums should the administration stop paying cost-sharing reductions (CSRs). The CBO projects the average monthly premiums would increase 20 percent next year and 25 percent by 2020.

August 3, 2017
National

The Senate has advanced the U.S. Food and Drug Administration’s (FDA) Reauthorization Act, which expands four separate user fee agreements on new drugs, generic drugs, medical devices, and biosimilars, and includes a provision to maximize the development of therapies for children with cancer.

July 28, 2017
National

The U.S. Food and Drug Administration announced today a new, comprehensive approach to confront nicotine addiction in the U.S. through the agency’s authority over tobacco products.